Emotional and behavioral responses to genetic testing for susceptibility to cancer

ONCOLOGY

Volumn 10, Issue 2, 1996, Pages 191-195+199

  Lerman, Caryn ^a   Croyle, Robert T ^b  

^a GEORGETOWN UNIVERSITY   (United States)

^b UNIVERSITY OF UTAH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTIVE BEHAVIOR; ANXIETY; BEHAVIOR; CONFIDENTIALITY; DECISION MAKING; DEPRESSION; DISEASE PREDISPOSITION; EMOTION; FAMILY; GENETIC COUNSELING; GENETIC SCREENING; GENETICS; GUILT; HEALTH STATUS; HUMAN; INFORMED CONSENT; INTERPERSONAL COMMUNICATION; MENTAL STRESS; NEOPLASM; PATIENT EDUCATION; PATIENT REFERRAL; PSYCHOLOGICAL ASPECT; REVIEW;

ADAPTATION, PSYCHOLOGICAL; ANXIETY; BEHAVIOR; CONFIDENTIALITY; DECISION MAKING; DEPRESSION; DISEASE SUSCEPTIBILITY; EMOTIONS; FAMILY; GENETIC COUNSELING; GENETIC SCREENING; GUILT; HEALTH STATUS; HUMANS; INFORMED CONSENT; NEOPLASMS; PATIENT EDUCATION; REFERRAL AND CONSULTATION; STRESS, PSYCHOLOGICAL; TRUTH DISCLOSURE;

EID: 0030074994     PISSN: 08909091     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (61)

1. Struewing J, Lerman C, Kase R, et al: Anticipated uptake and impact of genetic testing in hereditary breast and ovarian cancer families Cancer Epidemiol Biomarkers Prev 4:169-173, 1995.
2. Lerman C, Daly M, Masny A, et al: Attitudes about genetic testing for breast-ovarian cancer susceptibility. J Clin Oncol 12:843-850, 1994.
3. Lerman C, Seay J, Balshem A, et al: Interest in genetic testing among first-degree relatives of breast cancer patients. Am J Med Genet 57:385-392, 1995.
4. Croyle RT, Lerman C: Interest in genetic testing for colon cancer susceptibility: Cognitive and emotional correlates. Prev Med 22:284-292, 1993.
5. Lynch HT, Watson P, Conway TA, et al: DNA screening for breast/ovarian cancer susceptibility on linked markers: A family study. Arch Intern Med 153:1979-1987, 1993.
6. Li FP, Garber JE, Friend SH, et al: Recommendations on predictive testing for germ line p53 mutations among cancer-prone individuals. J Natl Cancer Inst 84:1156-1160, 1992.
7. Lerman C, Croyle R: Genetic testing for cancer susceptibility: Behavioral science issues. J Natl Cancer Inst 17:63-66, 1995.
8. Meissen G, Mastromauro CA, Kiely DK, et al. Understanding the decision to lake the predictive test for Huntington Disease. Am J Med Genet 39:404-410, 1991.
9. Zerres K, Stephe M: Attitudes to early diagnosis of polycystic kidney disease. Lancer 2:1395, 1986.
10. Lerman C, Croyle R: Psychological issues in genetic testing for breast cancer susceptibility. Arch Intern Med 154:609-616, 1994.
11. Miki Y, Swensen J, Shalluck-Eidens D, et al: A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266:66-71, 1994.
12. Fishel R, Lescoe MK, Rao MRS, et al: The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. Cell 75:1027-1038, 1993.
13. Lindblom A, Tannergard P, Werelius B, et al: Genetic mapping of a second locus predisposing to hereditary nonpolyposis colorectal cancer. Nat Genet 5:279-282, 1993.
14. Peltomaki P, Aaltonen L, Sistonen P, et al: Genetic mapping of a locus predisposing to human colorectal cancer. Science 260:810-812, 1993.
15. NTH News: NIH Components Take on Issues Related to Genetic Testing for Cancer Risk, pp 1-4. US Department of Health and Human Services, Public Health Service, National Institutes of Health, October 3, 1994.
16. ASHG Committee on BRCA1 Testing: Recommendations on genetic testing for breast and ovarian cancer susceptibility. Am J Hum Genet 55:ii-iv, 1994.
17. Kash KM, Holland JC, Halper MS, et al: Psychological distress and surveillance behaviors of women with a family history of breast cancer. J Natl Cancer Inst 84.24-30, 1992.
18. Lerman C, Daly M, Sands C, et al: Mammography adherence and psychological distress among women at risk for breast cancer. J Natl Cancer Inst 85:1074-1080, 1993.
19. Schwartz MD, Lerman C, Miller SM, et al: Coping disposition, perceived risk, and psychological distress among women at increased risk for ovarian cancer. Health Psychol 14:232-235, 1995.
20. Wardle FJ, Collins W, Pernet AL, et al: Psychological impact of screening for familial ovarian cancer. J Natl Cancer Inst 85:653-657, 1993.
21. Bloch M, Fahy M, Fox S, et al: Predictive testing for Huntington disease: II. Demographic characteristics, life-style patterns, attitudes, and psychosocial assessments of the first fifty-one test candidates. Am J Med Genet 32:217-224, 1989.
22. Ley P: Memory for medical information. Br J Soc Clin Psychol 18:245-256, 1979.
23. Meichenbaum D, Turk DC: Facilitating Treatment Adherence: A Practitioner's Handbook New York, Plenum Press, 1987.
24. Guttman N: Patient-practitioner information exchange as an asymmetrical social encounter: Do patients actually know what their practitioners think they know? in Schement JR, Ruben BD (eds). Between Communication and Information: Information and Behavior, vol 4, pp 293-317. New Brunswick, NJ, Transaction, 1993.
25. Waitzkin H: Information giving in medical care. J Health Soc Behav 26:81-101, 1985.
26. Lerman C, Daly M, Walsh WP, et al: Communication between patients with breast cancer and health care providers: Determinants and implications. Cancer 72.2612-2620, 1993.
27. Biesecker BB, Boehnke M, Calzone K, et al: Genetic counseling for families with inherited susceptibility to breast and ovarian cancer. JAMA 269.1970-1974, 1993.
28. Glanz K, Lerman C: Psychosocial impact of breast cancer: A critical review. Ann Behav Med 14:204-212, 1992.
29. Andersen BL: Psychological interventions for cancer patients to enhance the quality of life. J Consult Clin Psychol 60:552-568, 1992.
30. Huggins M, Bloch M, Wiggins S, et al: Predictive testing for Huntington disease in Canada: Adverse effects and unexpected results in those receiving a decreased risk. Am J Med Genet 42:508-515, 1992.
31. Tibben A, Duivenvoorden HJ, Vegter-van der Vlis M, et al. Presymptomatic DNA testing for Huntington disease. Identifying the need for psychological intervention Am J Med Genet 48 137-144, 1993.
32. Wiggins S, Whyte P, Huggins M. et al: The psychological consequences of predictive test-ing for Huntington's disease. N Engl J Med 327:1401-1405, 1992.
33. Croyle RT, Lerman C: Psychological impact of genetic testing, in Croyle R (ed): Psychosocial Effects of Screening for Disease Prevention and Detection. New York, Oxford University Press.
34. Nielson AC, Williams TA: Depression in ambulatory medical patients. Arch Gen Psychiatry 37:999-1004, 1980.
35. Frets PG, Verhage F, Niermeijer MF: Characteristics of the postcounseling reproductive decision-making process: An explorative study. Am J Med Genet 40:298-303, 1991.
36. Janis IL, Mann L: Decision Making: A Psychological Analysis of Conflict, Choice, and Commitment. New York, The Free Press, 1977.
37. Lerman C, Lustbader E, Rimer B, et al: Effects of individualized breast cancer risk counseling. A randomized trial. J Natl Cancer Inst (in press).
38. Blalock SJ, DeVellis BM, Sandler RS. Participation in fecal occult blood screening: A critical review. Prev Med 16:9-18, 1987.
39. Rimer BK: Understanding the acceptance of mammography by women Ann Behav Med 14:197-203, 1992.
40. Compas BE, Worsham NL, Epping-Jordan JE, et al: When mom or dad has cancer. Markers of psychological distress in cancer patients, spouses, and children. Health Psvchol 13:507-515, 1994.
41. Lichtman RR, Taylor SE, Wood JV, et al: Relations with children after breast cancer. The mother-daughter relationship at risk. J Psychosoc Oncol 2:1-19, 1984.
42. Kessler S: Forgotten person in the Huntington disease family. Am J Med Genet 48:145-150, 1993.
43. Sharpe NF: Informed consent and Huntington disease: A model for communication. Am J Med Genet 50:239-246, 1994.
44. Siminoff LA, Abeloff MD: Doctor-patient communication about breast cancer adjuvant therapy. J Clin Oncol 7:1192-1200, 1989.
45. Merz JF, Fischhoff B: Informed consent does not mean rational consent. J Leg Med 11:321-350, 1990.
46. Sharpe NF: Psychological aspects of genetic counseling: A legal perspective. Am J Med Genes 50:234-238, 1994.
47. Rainey LC: Effects of preparatory patient education on radiation oncology patients. Cancer 56:1056-1061, 1985.
48. Falek A: Sequential aspects of coping and other issues in decision making in genetic counseling, in Emery AH, Pullen, IM (eds.): Psychological Aspects of Genetic Counseling, pp 23-36. London, Academic Press, 1984.
49. Kessler S (ed.): Genetic Counseling: Psychological Dimensions. New York, Academic Press, 1979.
50. Carver CS, Pozo CP, Harris SD, et al: How coping mediates the effect of optimism on distress: A study of women with early stage breast cancer. J Pers Soc Psychol 65:375-390, 1993.
51. King MC, Rowell S, Love SM: Inherited breast and ovarian cancer: What are the risks? What are the choices? JAMA 269:1975-1980, 1993.
52. Lynch HT, Smyrk TC, Watson P, et al: Genetics, natural history, tumor spectrum, and pathology of hereditary nonpolyposis colorectal cancer. An updated review. Gastroenterol 104:1535-1549, 1993.
53. Owens RG, Ashcroft JJ, Leinster SJ, et al: Informal decision analysis with breast cancer patients: An aid to psychological preparation for surgery. J Psychosoc Oncol 5.23-33, 1987.
54. American Board of Medical Genetics, Inc: Bulletin of Information-Description of Examinations. National Board of Medical Examiners, 1992.
55. Ostrer H, Allen W, Crandall LA, et al. Insurance and genetic testing: Where are we now? Am J Hum Genet 52:565-577, 1993.
56. Billings PR, Kohn MA, Cuevas M, et al: Discrimination as a consequence of genetic testing. Am J Hum Genet 50: 476-482, 1992.
57. Andrews LB: Legal and ethical issues raised by the human genome project. Houston Law Review, vol 29 (spring), pp 149-184, 1992.
58. Powers M: Publication-related risks to privacy: The ethical implications of pedigree studies. IRB: Rev Hum Subj Res 15:7-11, 1993.
59. Nuffield Council on Bioethics: Genetic Screening: Ethical Issues. London, Nuffield Counsel, 1993.
60. De Wert G: Predictive testing for Huntington disease and the right not to know: Some ethical reflections. Birth Defects 28:133-138, 1992.
61. Croyle RT (ed.): Psychosocial Effects of Screening for Disease Prevention and Detection. New York, Oxford University Press, 1995.